687 results on '"Joos, Guy"'
Search Results
2. Trajectory of neutrophilic responses in a mouse model of pollutant-aggravated allergic asthma
3. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
4. Anti–Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry
5. Early Integrated Palliative Home Care and Standard Care for End-Stage COPD (EPIC): A Phase II Pilot RCT Testing Feasibility, Acceptability, and Effectiveness
6. Neutrophilic responses in a subacute and chronic mouse model of pollutant-aggravated allergic asthma
7. DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients
8. Asthma and air pollution: recent insights in pathogenesis and clinical implications
9. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report
10. Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses
11. Phenotype and Risk Burden of Sleep Apnea: A Population-Based Cohort Study
12. Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics
13. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
14. Asthma inflammatory phenotypes show differential microRNA expression in sputum
15. Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis Registry
16. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
17. Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis
18. A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease
19. RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD
20. Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice
21. “A palliative end-stage COPD patient does not exist”: a qualitative study of barriers to and facilitators for early integration of palliative home care for end-stage COPD
22. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry
23. Leptin as regulator of pulmonary immune responses: Involvement in respiratory diseases
24. Statins, systemic inflammation and risk of death in COPD: The Rotterdam study
25. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
26. Alcohol hyper‐responsiveness in chronic rhinosinusitis with nasal polyps
27. MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease
28. Mast Cell Stabilizing Drugs
29. Unravelling the role of miR-223 in the regulation of pollutant-aggravated allergic airway inflammation
30. Inhibiting RIPK1 kinase activity is protective in experimental models of COPD
31. Characterization of neutrophilic responses in a pollutant-aggravated asthma mouse model
32. Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA)
33. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country
34. Respiratory sensitization: Advances in assessing the risk of respiratory inflammation and irritation
35. New insights into the immunology of chronic obstructive pulmonary disease
36. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
37. MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation
38. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
39. Risk of Frailty in Elderly With COPD: A Population-Based Study
40. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study
41. Sympathomimetics and Xanthines in the Treatment of Asthma
42. Effects of Pulmonary Rehabilitation in Patients With Restrictive Lung Diseases
43. Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report
44. Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry
45. Clinical course of suspected familial versus sporadic IPFData from the PROOF-Next IPF registry
46. Long-term tolerability of real-life use of antifibrotic agents (AFA) in Idiopathic Pulmonary Fibrosis (IPF)
47. Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
48. Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation
49. Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease
50. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.